$17.84+0.65 (+3.78%)
WW International, Inc.
WW International, Inc. in the Healthcare sector is trading at $17.84. Wall Street consensus targets $28.33 (3 analysts), implying a +58.8% move over the next 12 months. The stock is currently 62% below its 52-week high of $46.95, remaining 21.6% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 82 is overbought against a weak tape. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
WW International, Inc. provides weight management products and services in the United States, Germany, Canada, and internationally. It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, a...
A number of stocks fell in the morning session after consumer discretionary stocks pulled back, led by a plunge in Lululemon as the company cut its full-year revenue guidance to $11.0–$11.15 billion from $11.35–$11.5 billion, citing weaker US consumer traffic, brand backlash on social media, and underperforming product launches.
In late May and early June 2026, Eli Lilly reported strong Phase 3 results for obesity, diabetes and oncology drugs, broadened coverage of its full obesity portfolio by all three major U.S. pharmacy benefit managers, and added Sesame and WW International’s Weight Watchers Med+ programs to its LillyDirect digital platform to improve access and support for patients. Together, these developments deepen Lilly’s presence across the entire cardiometabolic care journey, from gene-editing and...
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
Competition is intensifying after WeightWatchers' Med+ program became available through LillyDirect.
Shares of personal wellness company WeightWatchers (NASDAQ:WW) jumped 6.3% in the afternoon session after the company announced its Weight Watchers Med+ program is now accessible through Eli Lilly's digital healthcare platform, LillyDirect.